Repositioning: the fast track to new anti-malarial medicines?

BACKGROUND: Repositioning of existing drugs has been suggested as a fast track for developing new anti-malarial agents. The compound libraries of GlaxoSmithKline (GSK), Pfizer and AstraZeneca (AZ) comprising drugs that have undergone clinical studies in other therapeutic areas, but not achieved appr...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Lotharius, Julie, Gamo-Benito, Francisco Javier, Angulo-Barturen, Iñigo, Clark, Julie, Connelly, Michele, Ferrer-Bazaga, Santiago, Parkinson, Tanya, Viswanath, Pavithra, Bandodkar, Balachandra, Rautela, Nikhil, Bharath, Sowmya, Duffy, Sandra, Avery, Vicky M, Möhrle, Jörg J, Guy, R Kiplin, Wells, Timothy
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4021201/
https://ncbi.nlm.nih.gov/pubmed/24731288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-13-143
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы